述评

中国新生儿基因组计划:迈向遗传病治疗的崭新未来

  • 周文浩
展开
  • 广州医科大学附属妇女儿童医疗中心(广东 510620)

收稿日期: 2024-04-10

  网络出版日期: 2024-05-10

The China Neonatal Genome Project: towards a new future in the treatment of genetic diseases

  • Wenhao ZHOU
Expand
  • Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou510620, Guangdong, China

Received date: 2024-04-10

  Online published: 2024-05-10

摘要

随着科技的进步,新生儿遗传疾病的筛查与诊断技术已经取得了巨大的飞跃,特别是下一代测序(NGS)技术的应用,极大地提高了临床应用的效率和准确性。然而,面对快速诊断的同时,如何提供有效的治疗手段,改善患儿的总体预后,成为了新的挑战。本文将从中国新生儿基因组计划出发,全面而深入地探讨新生儿遗传疾病筛查与治疗的现状,聚焦个体化治疗手段研发与应用的关键问题,提出面向未来的努力方向。

本文引用格式

周文浩 . 中国新生儿基因组计划:迈向遗传病治疗的崭新未来[J]. 临床儿科杂志, 2024 , 42(5) : 379 -383 . DOI: 10.12372/jcp.2024.24e0329

Abstract

With the advancement of science and technology, screening and diagnostic techniques for neonatal genetic diseases have made great leaps forward, especially the application of next-generation sequencing (NGS) technology, which has greatly improved the efficiency and accuracy of clinical applications. However, in the face of rapid diagnosis, it has become a new challenge to provide effective treatments to improve the overall prognosis of children.This article will start from the China Neonatal Genome Project, comprehensively and in-depth discuss the current status of newborn genetic disease screening and treatment, focus on the key issues of personalized treatment research and application, and propose efforts for future directions.

参考文献

[1] Wu B, Kang W, Wang Y, et al. Application of full-spectrum rapid clinical genome sequencing improves diagnostic rate and clinical outcomes in critically ill infants in the China Neonatal Genomes Project[J]. Crit Care Med, 2021, 49(10): 1674-1683.
[2] National Organization for Rare Diseases. Global Genes Project[EB/OL]. https://rarediseases.org/
[3] Wang H, Qian Y, Lu Y, et al. Clinical utility of 24-h rapid trio-exome sequencing for critically ill infants[J]. NPJ Genom Med, 2020, 5: 20.
[4] Tan TY, Dillon OJ, Stark Z, et al. Diagnostic impact and cost-effectiveness of whole-exome sequencing for ambulant children with suspected monogenic conditions[J]. JAMA Pediatr, 2017, 171(9): 855-862.
[5] Meng L, Pammi M, Saronwala A, et al. Use of exome sequencing for infants in intensive care units: ascertainment of severe single-gene disorders and effect on medical management[J]. JAMA Pediatr, 2017, 171(12): e173438.
[6] 中国遗传学会遗传咨询分会. 中国新生儿基因组计划[DB/OL]. (2016) [2022-03-07]. http://www.cbgc.org.cn/projects/2016/0817/569.html?1487814155.
[7] Genetic Counseling Branch of Chinese Genetic Society. China Neonatal Genome Project[DB/OL]. (2016) [2022-03-07]. http://www.cbgc.org.cn/projects/2016/0817/569.html?148781415.
[8] Wojcik MH, Gold NB. Implications of genomic newborn screening for infant mortality[J]. Int J Neonatal Screen, 2023, 9(1): 12.
[9] Xiao T, Ni Q, Chen H, et al. High-risk phenotypes of genetic disease in a neonatal intensive care unit population[J]. Chin Med J (Engl), 2022, 135(5): 625-627.
[10] Wang J, Zhou WH. Epigenetic clocks in the pediatric population: when and why they tick?[J]. Chin Med J (Engl), 2021, 134(24): 2901-2910.
[11] Huang S, Liu S, Huang M, et al.. The Born in Guangzhou Cohort Study enables generational genetic discoveries[J]. Nature, 2024, 626(7999): 565-573.
[12] Zhu Y, Hu L, Yang L, et al. Association between expanded genomic sequencing combined with hearing screening and detection of hearing loss among newborns in a neonatal intensive care unit[J]. JAMA Netw Open, 2022, 5(7): e2220986.
[13] Tong F, Wang J, Xiao R, et al. Application of next generation sequencing in the screening of monogenic diseases in China, 2021: a consensus among Chinese newborn screening experts[J]. World J Pediatr, 2022, 18(4): 235-242.
[14] Singh S, Ojodu J, Kemper AR, et al. Implementation of newborn screening for conditions in the United States first recommended during 2010-2018[J]. Int J Neonatal Screen, 2023, 9(2): 20.
[15] Dong X, Xiao T, Chen B, et al. Precision medicine via the integration of phenotype-genotype information in neonatal genome project[J]. 自然科学基础研究: 英文版, 2022.
[16] Yang L, Kong Y, Dong X, et al. Clinical and genetic spectrum of a large cohort of children with epilepsy in China[J]. Genet Med, 2019, 21(3): 564-571.
[17] Yang L, Liu X, Li Z, et al.. Genetic aetiology of early infant deaths in a neonatal intensive care unit[J]. J Med Genet, 2020, 57(3): 169-177.
[18] Mei H, Dong X, Wu B, et al. Clinical and genetic etiologies of neonatal unconjugated hyperbilirubinemia in the China Neonatal Genomes Project[J]. J Pediatr, 2022, 243: 53-60.
[19] Bainbridge MN, Wiszniewski W, Murdock DR, et al. Whole-genome sequencing for optimized patient management[J]. Sci Transl Med, 2011, 3(87): 87re3.
文章导航

/